Phosphodiesterase inhibitors. Part 5: Hybrid PDE3/4 inhibitors as dual bronchorelaxant/anti-inflammatory agents for inhaled administration-Reference-Cited by-同舟云学术

Phosphodiesterase inhibitors. Part 5: Hybrid PDE3/4 inhibitors as dual bronchorelaxant/anti-inflammatory agents for inhaled administration

Published:2013-01 Issue:1 Volume:23 Page:375-381
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Ochiai Koji,Takita Satoshi,Kojima Akihiko,Eiraku Tomohiko,Iwase Kazuhiko,Kishi Tetsuya,Ohinata Akira,Yageta Yuichi,Yasue Tokutaro,Adams David R.,Kohno Yasushi

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference39 articles.

1. Roflumilast: clinical benefit in patients suffering from COPD

2. Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease

3. Roflumilast—an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial

4. PDE4 inhibitors: current status

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A modified all-in-one DMSO-activating and base releasing reagent for the Parikh-Doering-type benzylic oxidation reaction;Results in Chemistry;2024-07

2. One–Pot Assembly of 2‐Trifluoromethyl Benzothiazole and Benzoselenazole via Copper–Mediated Three–Component Cascade Reaction;Chemistry – An Asian Journal;2024-05-07

3. Pharmacophore Modelling and Virtual Screening Studies for the Discovery of Natural Product-based PDE 3/4 Dual Inhibitors for COPD;Letters in Drug Design & Discovery;2022-10

4. The Use of NHC Carbenes in Enantiopure Compounds Synthesis;Reference Module in Chemistry, Molecular Sciences and Chemical Engineering;2022

5. Radical Borylative Cyclization of Isocyanoarenes with N-Heterocyclic Carbene Borane: Synthesis of Borylated Aza-arenes;Organic Letters;2021-02-16